Correlation Between Novartis and Amarin PLC
Can any of the company-specific risk be diversified away by investing in both Novartis and Amarin PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Amarin PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Amarin PLC, you can compare the effects of market volatilities on Novartis and Amarin PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Amarin PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Amarin PLC.
Diversification Opportunities for Novartis and Amarin PLC
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Novartis and Amarin is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Amarin PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amarin PLC and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Amarin PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amarin PLC has no effect on the direction of Novartis i.e., Novartis and Amarin PLC go up and down completely randomly.
Pair Corralation between Novartis and Amarin PLC
Considering the 90-day investment horizon Novartis is expected to generate 24.67 times less return on investment than Amarin PLC. But when comparing it to its historical volatility, Novartis AG ADR is 5.39 times less risky than Amarin PLC. It trades about 0.08 of its potential returns per unit of risk. Amarin PLC is currently generating about 0.38 of returns per unit of risk over similar time horizon. If you would invest 45.00 in Amarin PLC on October 26, 2024 and sell it today you would earn a total of 19.00 from holding Amarin PLC or generate 42.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 94.74% |
Values | Daily Returns |
Novartis AG ADR vs. Amarin PLC
Performance |
Timeline |
Novartis AG ADR |
Amarin PLC |
Novartis and Amarin PLC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novartis and Amarin PLC
The main advantage of trading using opposite Novartis and Amarin PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Amarin PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amarin PLC will offset losses from the drop in Amarin PLC's long position.Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
Amarin PLC vs. Scilex Holding | Amarin PLC vs. Biogen Inc | Amarin PLC vs. Gilead Sciences | Amarin PLC vs. AstraZeneca PLC ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |